Microfluidic protein array shows promise for predicting mucositis during radiotherapy

As part of a larger effort to develop and validate their own microfluidic protein array technology for a variety of applications, researchers from the University of Connecticut have published a report demonstrating that their platform can sensitively and accurately detect a panel of cytokines associated with the risk of oral mucositis, an often debilitating and potentially fatal side effect of radiotherapy or high-dose chemotherapy for oral cancer.

Genome Web